Mastodon

D-panthenol-Nizhpharm (Ointment) Instructions for Use

Marketing Authorization Holder

Nizhpharm JSC (Russia)

Manufactured By

Hemofarm A.D. Vrsac Branch Plant Sabac (Serbia)

Quality Control Release

HEMOFARM, A.D. (Serbia)

ATC Code

D03AX03 (Dexpanthenol)

Active Substance

Dexpanthenol (Rec.INN registered by WHO)

Dosage Form

Bottle OTC Icon D-panthenol-Nizhpharm Ointment for external use 5%: tube 30 g

Dosage Form, Packaging, and Composition

Ointment for external use homogeneous, from white to light yellow in color.

1 g
Dexpanthenol 50 mg

Excipients: glycerol (glycerin), petrolatum, lanolin, liquid paraffin, solid paraffin, stearyl alcohol, cetyl alcohol, water.

30 g – aluminum tubes (1) – cardboard packs.

Clinical-Pharmacological Group

A drug improving trophism and tissue regeneration, for external use

Pharmacotherapeutic Group

Tissue repair stimulant

Pharmacological Action

Dexpanthenol is a derivative of pantothenic acid. Dexpanthenol is converted in the body into pantothenic acid, which is a component of coenzyme A and is involved in acetylation processes, in the synthesis of acetylcholine, corticosteroids, and porphyrins.

Furthermore, it participates in practically all metabolic processes (tricarboxylic acid cycle, metabolism of carbohydrates, fats and fatty acids, phospholipids, proteins), stimulates the regeneration of the skin and mucous membranes, normalizes cellular metabolism, accelerates mitosis and increases the strength of collagen fibers. It has a regenerating, metabolic, and weak anti-inflammatory effect.

Pharmacokinetics

When applied topically, it is rapidly absorbed by the skin and converted into pantothenic acid, binds to plasma proteins (mainly to beta-globulin and albumin). The concentration in blood is 0.5-1 mg/l, in blood serum – 100 µg/l. Pantothenic acid is not metabolized in the body (except for incorporation into CoA), and is excreted unchanged.

Indications

  • Dry skin;
  • Violation of the integrity of the skin and soft tissues;
  • Minor injuries;
  • Burns (thermal and sunburn);
  • Abrasions;
  • Bullous dermatitis;
  • Abscess;
  • Furuncle;
  • Trophic leg ulcers;
  • Bedsores;
  • Cracks;
  • Aseptic postoperative wounds;
  • Poorly healing skin grafts;
  • Treatment and prevention of cracks and inflammation of the mammary gland nipples during lactation;
  • Care for infants;
  • Prevention and treatment of diaper rash;
  • Skin healing for minor injuries;
  • Diaper erythema in infants.

ICD codes

ICD-10 code Indication
L02 Cutaneous abscess, furuncle and carbuncle
L13 Other bullous disorders
L22 Diaper dermatitis
L30.4 Erythematous intertrigo
L89 Decubitus ulcer and pressure area
L98.4 Chronic skin ulcer, not elsewhere classified
N64.0 Fissure and fistula of nipple
T14.0 Superficial injury of unspecified body region (including abrasion, bruise, contusion, hematoma, bite of nonvenomous insect)
T14.1 Open wound of unspecified body region
T30 Burns and corrosions of unspecified body region
Z94.6 Presence of transplanted bone
ICD-11 code Indication
1B75.0 Furuncle
1B75.1 Carbuncle
1B75.2 Furunculosis
1B75.3 Pyogenic skin abscess
EA40 Tropical phagedenic ulcer
EF60 Ischemic ulceration of the skin
EH40.10 Diaper dermatitis
EH90.Z Pressure ulcer of unspecified degree
EH92 Dermatoses provoked by friction or mechanical impact
EH92.1 Blister due to friction
EK02.20 Intertriginous dermatitis due to friction, sweating or contact with body fluids
EM0Z Unspecified skin disorder
GB23.1 Fissure or fistula of nipple
ME60.2 Ulcerative skin lesion of unspecified nature
ND56.0 Superficial injury of unspecified body region
ND56.1 Open wound of unspecified body region
NE11 Burn of unspecified body region
QB63.5 Presence of transplanted bone

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Externally. For treating wounds, diaper rash, abscesses, bedsores, dermatitis, for breast care, for infants – 5% ointment is applied 2-3 times/day to the affected surface in a thin layer and gently rubbed in depending on the indication; to the area of the mammary gland nipple, the ointment is applied as a compress after each breastfeeding.

For infants D-panthenol-Nizhpharm is applied to the back, buttocks, and groin area after each change of underwear or water procedure.

Adverse Reactions

Possible occurrence of allergic reactions; if they appear, discontinue use of the drug.

Contraindications

  • Hypersensitivity to the components of the drug.

Use in Pregnancy and Lactation

Can be used during pregnancy and the breastfeeding period.

Pediatric Use

For treating wounds, diaper rash, abscesses, bedsores, dermatitis in infants – 5% ointment is applied 2-3 times/day to the affected surface in a thin layer and gently rubbed in depending on the indication.

For infants D-panthenol-Nizhpharm is applied to the back, buttocks, and groin area after each change of underwear or water procedure.

Special Precautions

Treatment of poorly healing skin grafts and trophic ulcers should be carried out under the supervision of the attending physician.

Do not apply to weeping wounds.

Drug Interactions

Not identified.

Storage Conditions

Store at a temperature from 15°C (59°F) to 25°C (77°F). Keep out of reach of children.

Shelf Life

Shelf life – 5 years.

Dispensing Status

The drug is approved for use as an over-the-counter product.

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

TABLE OF CONTENTS